Correlation Between Protalix Biotherapeutics and Dyadic International

Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protalix Biotherapeutics and Dyadic International, you can compare the effects of market volatilities on Protalix Biotherapeutics and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Dyadic International.

Diversification Opportunities for Protalix Biotherapeutics and Dyadic International

-0.48

Correlation Coefficient

Protalix Biotherapeutics  Dyadic International

Very good diversification

The 3 months correlation between Protalix and Dyadic is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Dyadic International go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Dyadic International

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.81 times more return on investment than Dyadic International. However, Protalix Biotherapeutics is 1.23 times less risky than Dyadic International. It trades about 0.18 of its potential returns per unit of risk. Dyadic International is currently generating about -0.08 per unit of risk. If you would invest  178.00  in Protalix Biotherapeutics on December 26, 2024 and sell it today you would earn a total of  75.00  from holding Protalix Biotherapeutics or generate 42.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Protalix Biotherapeutics  vs.  Dyadic International

Protalix Biotherapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dyadic International

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dyadic International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Protalix Biotherapeutics and Dyadic International

The main advantage of trading using opposite Protalix Biotherapeutics and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.

The idea behind Protalix Biotherapeutics and Dyadic International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.